Meridian Bioscience Inc. (VIVO) Lowered to "Hold" at TheStreet
VIVO has been the subject of a number of other reports. Zacks Investment Research raised Meridian Bioscience from a "sell" rating to a "hold" rating in a research report on Wednesday, July 13th.
from Biotech News
0 Comments